Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4HCN1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.636 |
CLV_NRD_NRD_1 | 143 | 145 | PF00675 | 0.640 |
CLV_NRD_NRD_1 | 149 | 151 | PF00675 | 0.694 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.525 |
CLV_PCSK_KEX2_1 | 143 | 145 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.525 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.497 |
CLV_Separin_Metazoa | 41 | 45 | PF03568 | 0.588 |
DEG_APCC_DBOX_1 | 134 | 142 | PF00400 | 0.344 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 153 | 159 | PF00134 | 0.304 |
DOC_MAPK_gen_1 | 189 | 197 | PF00069 | 0.626 |
DOC_MAPK_HePTP_8 | 88 | 100 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 189 | 197 | PF00069 | 0.585 |
DOC_MAPK_MEF2A_6 | 91 | 100 | PF00069 | 0.400 |
LIG_14-3-3_CanoR_1 | 135 | 139 | PF00244 | 0.391 |
LIG_FHA_1 | 182 | 188 | PF00498 | 0.681 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.594 |
LIG_FHA_2 | 3 | 9 | PF00498 | 0.617 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.410 |
LIG_PDZ_Class_2 | 211 | 216 | PF00595 | 0.568 |
LIG_RPA_C_Fungi | 139 | 151 | PF08784 | 0.422 |
LIG_SH2_STAT5 | 167 | 170 | PF00017 | 0.315 |
LIG_SH3_3 | 180 | 186 | PF00018 | 0.422 |
LIG_SH3_3 | 190 | 196 | PF00018 | 0.439 |
LIG_TRAF2_1 | 202 | 205 | PF00917 | 0.471 |
LIG_TRAF2_1 | 73 | 76 | PF00917 | 0.410 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.421 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.576 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.470 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.510 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.611 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.535 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.347 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.505 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.330 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.469 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.664 |
MOD_N-GLC_1 | 102 | 107 | PF02516 | 0.426 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.457 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.431 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.532 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.582 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.598 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.463 |
MOD_PK_1 | 144 | 150 | PF00069 | 0.432 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.417 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.450 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.424 |
MOD_Plk_1 | 155 | 161 | PF00069 | 0.456 |
MOD_SUMO_for_1 | 98 | 101 | PF00179 | 0.485 |
TRG_DiLeu_BaEn_1 | 102 | 107 | PF01217 | 0.426 |
TRG_ENDOCYTIC_2 | 167 | 170 | PF00928 | 0.312 |
TRG_ER_diArg_1 | 148 | 150 | PF00400 | 0.448 |
TRG_ER_diArg_1 | 80 | 82 | PF00400 | 0.382 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJU2 | Leptomonas seymouri | 55% | 100% |
A0A3S7WXJ0 | Leishmania donovani | 76% | 95% |
A4I055 | Leishmania infantum | 76% | 95% |
E9AW18 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 95% |
Q4QBF8 | Leishmania major | 75% | 100% |